A detailed history of Kent Lake Capital LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Kent Lake Capital LLC holds 1,738,102 shares of STIM stock, worth $2.29 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
1,738,102
Previous 1,021,151 70.21%
Holding current value
$2.29 Million
Previous $4.86 Million 35.64%
% of portfolio
1.44%
Previous 2.32%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.73 - $4.81 $1.24 Million - $3.45 Million
716,951 Added 70.21%
1,738,102 $3.13 Million
Q1 2024

May 15, 2024

SELL
$2.68 - $4.8 $254,305 - $455,472
-94,890 Reduced 8.5%
1,021,151 $4.86 Million
Q4 2023

Feb 14, 2024

BUY
$1.05 - $2.9 $430,176 - $1.19 Million
409,692 Added 58.0%
1,116,041 $3.24 Million
Q2 2023

Aug 14, 2023

SELL
$2.07 - $2.92 $286,127 - $403,619
-138,226 Reduced 16.37%
706,349 $1.52 Million
Q1 2023

May 15, 2023

SELL
$2.81 - $6.71 $717,744 - $1.71 Million
-255,425 Reduced 23.22%
844,575 $2.46 Million
Q4 2022

Feb 14, 2023

BUY
$2.74 - $6.87 $1.96 Million - $4.92 Million
716,304 Added 186.69%
1,100,000 $7.56 Million
Q3 2022

Nov 14, 2022

BUY
$2.35 - $4.66 $901,685 - $1.79 Million
383,696 New
383,696 $1.22 Million
Q4 2021

Feb 14, 2022

SELL
$3.87 - $6.59 $3.6 Million - $6.13 Million
-930,709 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$6.22 - $15.54 $1.3 Million - $3.25 Million
-209,144 Reduced 18.35%
930,709 $6.11 Million
Q2 2021

Aug 16, 2021

SELL
$10.15 - $17.25 $678,314 - $1.15 Million
-66,829 Reduced 5.54%
1,139,853 $18.3 Million
Q1 2021

May 17, 2021

SELL
$10.6 - $21.27 $374,370 - $751,213
-35,318 Reduced 2.84%
1,206,682 $14.9 Million
Q4 2020

Feb 12, 2021

BUY
$4.95 - $11.45 $6.15 Million - $14.2 Million
1,242,000 New
1,242,000 $13.8 Million

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $35.7M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Kent Lake Capital LLC Portfolio

Follow Kent Lake Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kent Lake Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kent Lake Capital LLC with notifications on news.